Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / David Berman
Person

David Berman

Tracked across 1 events · 6 articles · First seen Jun 08, 2026 · Last active Jun 09, 2026

Sentiment
60
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 60
Tech
Oxford, Moderna develop cancer vaccine
The University of Oxford and pharmaceutical firm Moderna>>> have developed a pioneering mRNA vaccine, mRNA-4194, aimed at preventing bowel and ovarian cancers in individuals with Hereditary nonpolyposis colorectal cancer>>>. A clinical trial, named Intercept-Lynch, is…
Impact: David Berman>>>, Chief Development Officer at Moderna>>>, expressed pride in the innovation and collaboration, highlighting Moderna>>>'s commitment to advancing mRNA research.
Jun 08, 2026 · 6 articles
NEWSDESK
Track David Berman live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.